Möbius Cornelia, Blinzler Christian, Schwab Stefan, Köhrmann Martin, Breuer Lorenz
Department of Neurology, Universitätsklinikum Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany.
Department of Neurology, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Germany.
BMC Neurol. 2018 Aug 29;18(1):129. doi: 10.1186/s12883-018-1126-0.
The SPAN-100 index adds patient age and baseline NIHSS-score and was introduced to predict clinical outcome after acute ischemic stroke (AIS). Even with high NIHSS-scores younger patients cannot reach a SPAN-100-positive status (index ≥100). We aimed to evaluate the SPAN-100 index among a large, contemporary cohort of i.v.-thrombolysed AIS-patients and exclusively among older patients who can at least theoretically achieve SPAN-100-positivity.
The SPAN-100 index was applied to AIS-patients receiving i.v.-thrombolysis (IVT) in our institution between 01/2006 and 01/2013. Clinical outcome and symptomatic intracerebral hemorrhage rates were compared between SPAN-100-positive and -negative patients. Furthermore we excluded patients < 65 years, without any theoretical chance to achieve SPAN-100-positivity, and re-evaluated the index (SPAN-100 index).
SPAN-100-positive IVT-patients (124/1002) had a 9-fold increased risk for unfavorable outcome compared to SPAN-negative patients (OR 9.39; 95% CI 5.87-15.02; p < 0.001). The odds ratio for mortality was 7.48 (95% CI 4.90-11.43; p < 0.001). No association was found between SPAN-100-positivity and sICH-incidence (OR 0.88; 95% CI 0.31-2.53; p = 0.810). SPAN-100-positivity (124/741) was associated with an 8-fold increased risk for unfavorable outcome (OR 7.6; 95% CI 4.71-12.22; p < 0.001) but not associated with higher sICH-rates (OR 0.86; 95% CI 0.29-2.53; p < 0.001).
Also for patients ≥65 years the SPAN-100 index can be a fast, easy method to predict clinical outcome of IVT-patients in everyday practice. However, it should not be used to determine the risk of sICH after IVT. Based on a SPAN-positive status IVT should not be withheld from AIS-patients merely because of feared sICH-complications.
SPAN - 100指数纳入了患者年龄和基线美国国立卫生研究院卒中量表(NIHSS)评分,用于预测急性缺血性卒中(AIS)后的临床结局。即使NIHSS评分较高,年轻患者也无法达到SPAN - 100阳性状态(指数≥100)。我们旨在评估大量接受静脉溶栓治疗的当代AIS患者队列中的SPAN - 100指数,且仅评估至少在理论上可达到SPAN - 100阳性的老年患者。
将SPAN - 100指数应用于2006年1月至2013年1月在我院接受静脉溶栓治疗(IVT)的AIS患者。比较SPAN - 100阳性和阴性患者的临床结局及症状性脑出血发生率。此外,我们排除了年龄<65岁、在理论上没有机会达到SPAN - 100阳性的患者,并重新评估该指数(SPAN - 100指数)。
SPAN - 100阳性的IVT患者(124/1002)与SPAN阴性患者相比,不良结局风险增加9倍(比值比9.39;95%可信区间5.87 - 15.02;p<0.001)。死亡率的比值比为7.48(95%可信区间4.90 - 11.43;p<0.001)。未发现SPAN - 100阳性与症状性脑出血发生率之间存在关联(比值比0.88;95%可信区间0.31 - 2.53;p = 0.810)。SPAN - 100阳性(124/741)与不良结局风险增加8倍相关(比值比7.6;95%可信区间4.71 - 12.22;p<0.001),但与较高的症状性脑出血发生率无关(比值比0.86;95%可信区间0.29 - 2.53;p<0.001)。
对于≥65岁的患者,SPAN - 100指数在日常实践中也可以是一种快速、简便的预测IVT患者临床结局的方法。然而,它不应被用于确定IVT后症状性脑出血的风险。基于SPAN阳性状态,不应仅仅因为担心症状性脑出血并发症而不给AIS患者进行IVT治疗。